AXGN — Axogen Inc. stock price and chart

AXGN

$36.17+2.64%

as of close, Oct 20, 2026

☾ AH $36.17 +2.64%

Axogen Inc.Stock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.006% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEE

20162019202120242026

5.010.015.020.025.030.035.040.045.050.055.0010.0M$36.17

2026-10-20

Price$36.17

MA20$42.46

MA50$33.51

Vol3.9M

What would $1,000 invested in AXGN be worth today? →

AXGN returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $36.17
YTD price return: +10.51%
YTD total return: +10.51%
Next earnings: Oct 28, 2026 · Before open
Market cap: 1.9B2016-12 296.1M2026-10 1.9B+556.8% over the window
Enterprise value: 1.9B
Shares outstanding: 53.8M2016-06 30.1M2026-06 53.8M+78.4% over the window
52W low: $16.65
52W high: $52.91
From 52W high: -31.64%
From 52W low: +117.24%
52W range: 54%

Volume

Rel volume: 0.64×
30D volume: 1.5M
30D $ vol: 61M

Fundamentals

Sales (ttm): 251.2M2016-06 34.5M2026-06 251.2M+629.0% over the window
Sales/share: $4.672016-06 $1.142026-06 $4.67+308.6% over the window
EPS (ttm): -$0.672019-12 -$0.742026-06 -$0.67-9.6% over the window
FCF (ttm): 8.6M2016-06 -15.2M2026-06 8.6M-156.6% over the window
FCF/share: $0.162016-06 -$0.502026-06 $0.16-131.7% over the window
Book value/share: $4.772016-06 $0.092026-06 $4.77+5042.2% over the window
Net margin: -13.36%2016-06 -37.9%2026-06 -13.4%-64.8% over the window
ROE: -13.09%2016-06 -467.9%2026-06 -13.1%-97.2% over the window
ROA: -11.00%2016-06 -41.2%2026-06 -11.0%-73.3% over the window
Debt / equity: 0.00×2016-12 1.362026-06 0.00-100.0% over the window
Current ratio: 6.602016-06 7.582026-06 6.60-13.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: +23.58%2025-06-30 → 2026-06-30203.3M → 251.2M (+23.6% total)+19.29%2023-06-30 → 2026-06-30147.9M → 251.2M (+69.8% total)+13.99%2021-06-30 → 2026-06-30130.5M → 251.2M (+92.4% total)+21.98%2016-06-30 → 2026-06-3034.5M → 251.2M (+629.0% total)
FCF: +74.04%2025-06-30 → 2026-06-304.9M → 8.6M (+74.0% total)n/an/an/a
Shares: +16.85%2025-06-30 → 2026-06-3046M → 53.8M (+16.8% total)+7.74%2023-06-30 → 2026-06-3043M → 53.8M (+25.1% total)+5.37%2021-06-30 → 2026-06-3041.4M → 53.8M (+29.9% total)+5.96%2016-06-30 → 2026-06-3030.1M → 53.8M (+78.4% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +5.76%2025-06-30 → 2026-06-30$4.42 → $4.67 (+5.8% total)+10.72%2023-06-30 → 2026-06-30$3.44 → $4.67 (+35.7% total)+8.18%2021-06-30 → 2026-06-30$3.15 → $4.67 (+48.2% total)+15.12%2016-06-30 → 2026-06-30$1.14 → $4.67 (+308.6% total)
FCF/share: +48.94%2025-06-30 → 2026-06-30$0.11 → $0.16 (+48.9% total)n/an/an/a
Book value/share: +95.43%2025-06-30 → 2026-06-30$2.44 → $4.77 (+95.3% total)+28.23%2023-06-30 → 2026-06-30$2.26 → $4.77 (+110.9% total)+10.70%2021-06-30 → 2026-06-30$2.87 → $4.77 (+66.2% total)+48.30%2016-06-30 → 2026-06-30$0.09 → $4.77 (+5042.2% total)
Price: +113.25%2025-10-20 → 2026-10-20$16.97 → $36.17 (+113.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+107.61%2023-10-20 → 2026-10-20$4.04 → $36.17 (+795.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.88%2021-10-20 → 2026-10-20$14.61 → $36.17 (+147.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.05%2016-10-19 → 2026-10-20$8.90 → $36.17 (+306.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +113.25%2025-10-20 → 2026-10-20$16.97 → $36.17 (+113.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+107.61%2023-10-20 → 2026-10-20$4.04 → $36.17 (+795.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+19.88%2021-10-20 → 2026-10-20$14.61 → $36.17 (+147.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.05%2016-10-19 → 2026-10-20$8.90 → $36.17 (+306.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -54.0×2016-12 -23.892026-10 -57.96+142.7% over the window
Fwd P/E: 48.0×
P/S (ttm)Market cap ÷ TTM revenue.: 7.7×2016-12 7.892026-10 7.74-1.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 7.6×2016-12 268.272026-10 7.59-97.2% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 226.2×2016-12 -20.132026-10 226.16-1223.8% over the window
EV/Sales (ttm): 7.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 0.44%2016-09 -5.0%2026-06 0.3%-107.0% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 53.8M ÷ 46.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -16.85%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-16.85%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($499.2M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -16.85%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-134M) ÷ today's market cap ($1.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -6.89%2016-09 0.0%2026-06 -5.4%-680490.8% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-134M + TTM dividends $0) ÷ today's market cap ($1.9B). Same caveat as the cash buyback yield.: -6.89%2016-09 0.0%2026-06 -5.4%-680490.8% over the window

Vs own 10Y history

P/S: 69th
P/B: 68th

Bar = where today’s multiple sits in AXGN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.64%

+0.00%

-18.22%

-8.38%

YTD

+10.51%

+113.14%

+147.57%

Financial statements

Open full AXGN financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

AXGN — Axogen Inc. price, chart and key statistics